Sign in to view content

Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME

Seenu M. Hariprasad, MD

Video
Published 2018

Related

Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019
Correlation of Peripheral Nonperfusion on Ultra-widefield Fluorescein Angiography with Macular Flow Loss on OCT Angiography in Sickle Cell Retinopathy
Adrienne W. Scott, MD, FASRS
Annual Meeting Talks
2018
Advanced Image Analysis and Machine-Learning Assessment of the Impact of Aflibercept on Anatomic Feature and Flow Dynamics in the PERMEATE Study
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more